Description
DAONIL – BLISTER 5MG contains 5mg of Glibenclamide per tablet, an oral antidiabetic medication belonging to the sulfonylurea class. Manufactured by Sanofi, Daonil works by stimulating the pancreatic beta cells to release more insulin, thereby lowering blood sugar levels. It is a cornerstone in the management of Type 2 Diabetes Mellitus, complementing diet, exercise, and weight management programs to achieve optimal glycemic control.
Typically presented in convenient blister packs, Daonil 5mg is taken orally, usually once daily with the first main meal. As a prescription-only medication, strict adherence to medical guidance is crucial. A primary concern with Daonil is the risk of hypoglycemia (low blood sugar), which can manifest as weakness, sweating, dizziness, and confusion. Patients must be educated on recognizing and treating these symptoms immediately. Other potential side effects include gastrointestinal upset and weight gain. It is contraindicated in Type 1 Diabetes, severe liver or kidney disease, and pregnancy, and careful monitoring is required due to various drug interactions.
